alert icon Coronavirus

Think you may have COVID-19?
Find out where you can get tested

Need a vaccine or booster?
Schedule today

Coming to a Cleveland Clinic location?
Visitation and mask requirements

Cardiac Consult

Cardiac Consult

A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.

Dr. Steve Nissen

Featured Episode

Technology-Assisted Self-Selection for Nonprescription Statin Therapy

Access to medical providers can be a challenge for many patients. Steven Nissen, MD, Cleveland Clinic Heart, Vascular and Thoracic Institute Chief Academic Officer, describes one approach to help improve patient access to nonprescription statin therapy. Technology-assisted self-selection showed to be an effect method of screening patients compared to clinician screening.

Play Now
All Cardiac Consult Episodes

All Cardiac Consult Episodes

May 12, 2022

Talking Tall Rounds®: Adult Congenital Heart Disease & Pulmonary Hypertension Combined Clinic

Tamanna Singh, MD and Adriano Tonelli, MD discuss non-invasive and invasive cardiopulmonary exercise testing.

Play Now

May 5, 2022

APOLLO Trial Finds Experimental ‘Gene Silencing’ Therapy Reduces Lipoprotein(a) By Up To 98%

Presented at the American College of Cardiology as a Late-Breaking Clinical Trial, the Cleveland Clinic-led APOLLO trial explores siRNA therapy as a treatment option to help prevent premature heart disease in people with high levels of Lp-a. This condition is estimated to affect 64 million people in the United States and 1.4 billion people worldwide. It is estimated that nearly 20 to 25 percent of the world's population has elevated Lp-a Dr. Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular and Thoracic Institute at Cleveland Clinic explains the purpose, patient selection, and findings of APOLLO.

Play Now

April 28, 2022

Talking Tall Rounds®: Novel Advances in the Treatment of Aortitis

Dr. Sagar Kalahasti provides an overview of novel advances in the treatment of aortitis.

Play Now

April 21, 2022

VALOR-HCM Shows Promise for Patients with Symptomatic Hypertrophic Cardiomyopathy

Presented at ACC as a Late-Breaking Clinical Trial, VALOR-HCM explores Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive hypertrophic cardiomyopathy. Dr. Steven Nissen and Dr. Milind Desai, principal investigator, discuss the purpose, patient selection, and findings of the VALOR-HCM trial.

Play Now
More Cleveland Clinic Podcasts
Back to Top